Listeria monocytogenes requires cellular respiration for NAD+ regeneration and pathogenesis

  1. Rafael Rivera-Lugo
  2. David Deng
  3. Andrea Anaya-Sanchez
  4. Sara Tejedor-Sanz
  5. Eugene Tang
  6. Valeria M Reyes Ruiz
  7. Hans B Smith
  8. Denis V Titov
  9. John Demian Sauer
  10. Eric P Skaar
  11. Caroline M Ajo-Franklin
  12. Daniel A Portnoy
  13. Samuel H Light  Is a corresponding author
  1. University of California, Berkeley, United States
  2. Rice University, United States
  3. Vanderbilt University Medical Center, United States
  4. University of Wisconsin-Madison, United States
  5. University of Chicago, United States

Abstract

Cellular respiration is essential for multiple bacterial pathogens and a validated antibiotic target. In addition to driving oxidative phosphorylation, bacterial respiration has a variety of ancillary functions that obscure its contribution to pathogenesis. We find here that the intracellular pathogen Listeria monocytogenes encodes two respiratory pathways which are partially functionally redundant and indispensable for pathogenesis. Loss of respiration decreased NAD+ regeneration, but this could be specifically reversed by heterologous expression of a water-forming NADH oxidase (NOX). NOX expression fully rescued intracellular growth defects and increased L. monocytogenes loads >1,000-fold in a mouse infection model. Consistent with NAD+ regeneration maintaining L. monocytogenes viability and enabling immune evasion, a respiration-deficient strain exhibited elevated bacteriolysis within the host cytosol and NOX expression rescued this phenotype. These studies show that NAD+ regeneration represents a major role of L. monocytogenes respiration and highlight the nuanced relationship between bacterial metabolism, physiology, and pathogenesis.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Rafael Rivera-Lugo

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2346-2297
  2. David Deng

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  3. Andrea Anaya-Sanchez

    Graduate Group in Microbiology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  4. Sara Tejedor-Sanz

    Department of Biosciences, Rice University, Houston, United States
    Competing interests
    No competing interests declared.
  5. Eugene Tang

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  6. Valeria M Reyes Ruiz

    Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  7. Hans B Smith

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  8. Denis V Titov

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    Denis V Titov, is a co-inventor on a filed patent describing the use of NOX. (US Patent App. 15/749,218).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5677-0651
  9. John Demian Sauer

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9367-794X
  10. Eric P Skaar

    Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  11. Caroline M Ajo-Franklin

    Department of Biosciences, Rice University, Houston, United States
    Competing interests
    No competing interests declared.
  12. Daniel A Portnoy

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  13. Samuel H Light

    Department of Microbiology, University of Chicago, Chicago, United States
    For correspondence
    samlight@uchicago.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8074-1348

Funding

National Institutes of Health (T32GM007215)

  • Hans B Smith

Searle Scholars Program

  • Samuel H Light

National Institutes of Health (R01AI137070)

  • John Demian Sauer

National Institutes of Health (R01AI073843)

  • Eric P Skaar

National Institutes of Health (R01AI073843)

  • Eric P Skaar

National Institutes of Health (1P01AI063302)

  • Daniel A Portnoy

National Institutes of Health (1R01AI27655)

  • Daniel A Portnoy

National Institutes of Health (K22AI144031)

  • Samuel H Light

National Academies of Sciences, Engineering, and Medicine (Ford Foundation Fellowship)

  • Rafael Rivera-Lugo

University of California (Dissertation-Year Fellowship)

  • Rafael Rivera-Lugo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal work was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Protocols were reviewed and approved by the Animal Care and Use Committee at the University of California, Berkeley (AUP 2016-05-8811).

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,934
    views
  • 441
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rafael Rivera-Lugo
  2. David Deng
  3. Andrea Anaya-Sanchez
  4. Sara Tejedor-Sanz
  5. Eugene Tang
  6. Valeria M Reyes Ruiz
  7. Hans B Smith
  8. Denis V Titov
  9. John Demian Sauer
  10. Eric P Skaar
  11. Caroline M Ajo-Franklin
  12. Daniel A Portnoy
  13. Samuel H Light
(2022)
Listeria monocytogenes requires cellular respiration for NAD+ regeneration and pathogenesis
eLife 11:e75424.
https://doi.org/10.7554/eLife.75424

Share this article

https://doi.org/10.7554/eLife.75424

Further reading

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Flavie Coquel, Sing-Zong Ho ... Philippe Pasero
    Research Article

    Cancer cells display high levels of oncogene-induced replication stress (RS) and rely on DNA damage checkpoint for viability. This feature is exploited by cancer therapies to either increase RS to unbearable levels or inhibit checkpoint kinases involved in the DNA damage response. Thus far, treatments that combine these two strategies have shown promise but also have severe adverse effects. To identify novel, better-tolerated anticancer combinations, we screened a collection of plant extracts and found two natural compounds from the plant, Psoralea corylifolia, that synergistically inhibit cancer cell proliferation. Bakuchiol inhibited DNA replication and activated the checkpoint kinase CHK1 by targeting DNA polymerases. Isobavachalcone interfered with DNA double-strand break repair by inhibiting the checkpoint kinase CHK2 and DNA end resection. The combination of bakuchiol and isobavachalcone synergistically inhibited cancer cell proliferation in vitro. Importantly, it also prevented tumor development in xenografted NOD/SCID mice. The synergistic effect of inhibiting DNA replication and CHK2 signaling identifies a vulnerability of cancer cells that might be exploited by using clinically approved inhibitors in novel combination therapies.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.